Filing Details

Accession Number:
0001562180-23-008573
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-12-28 16:39:30
Reporting Period:
2023-12-26
Accepted Time:
2023-12-28 16:39:30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1710072 Edgewise Therapeutics Inc. EWTX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1655016 C Jonathan Fox C/O Edgewise Therapeutics, Inc.
1715 38Th Street
Boulder CO 80301
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-12-26 10,857 $9.30 10,857 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct